Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Manipulating cardiac contractility in heart failure: data from mice and men.

× No keyword cloud information.

42 in total

1. Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a.

Authors: Ilka Pinz; Rong Tian; Darrell Belke; Eric Swanson; Wolfgang Dillmann; Joanne S Ingwall
Journal: J Biol Chem Date: 2011-01-29 Impact factor: 5.157

2. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness.

Authors: Alexandre J S Ribeiro; Yen-Sin Ang; Ji-Dong Fu; Renee N Rivas; Tamer M A Mohamed; Gadryn C Higgs; Deepak Srivastava; Beth L Pruitt
Journal: Proc Natl Acad Sci U S A Date: 2015-09-28 Impact factor: 11.205

Review 3. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.

Authors: Thomas Kislinger; Anthony O Gramolini; David H MacLennan; Andrew Emili
Journal: J Am Soc Mass Spectrom Date: 2005-08 Impact factor: 3.109

4. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.

Authors: Douglas M Anderson; Kelly M Anderson; Chi-Lun Chang; Catherine A Makarewich; Benjamin R Nelson; John R McAnally; Prasad Kasaragod; John M Shelton; Jen Liou; Rhonda Bassel-Duby; Eric N Olson
Journal: Cell Date: 2015-01-29 Impact factor: 41.582

5. Bitransgenesis with beta(2)-adrenergic receptors or adenylyl cyclase fails to improve beta(1)-adrenergic receptor cardiomyopathy.

Authors: Natalia Petrashevskaya; Brigitte R Gaume; Kathryn A Mihlbachler; Gerald W Dorn; Stephen B Liggett
Journal: Clin Transl Sci Date: 2008-12 Impact factor: 4.689

6. Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.

Authors: Nathalie Mougenot; Delphine Mika; Gabor Czibik; Elizabeth Marcos; Shariq Abid; Amal Houssaini; Benjamin Vallin; Aziz Guellich; Hind Mehel; Daigo Sawaki; Grégoire Vandecasteele; Rodolphe Fischmeister; Roger J Hajjar; Jean-Luc Dubois-Randé; Isabelle Limon; Serge Adnot; Geneviève Derumeaux; Larissa Lipskaia
Journal: Cardiovasc Res Date: 2019-10-01 Impact factor: 10.787

7. The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy.

Authors: Stephen W Luckey; Lori A Walker; Tyson Smyth; Jason Mansoori; Antke Messmer-Kratzsch; Anthony Rosenzweig; Eric N Olson; Leslie A Leinwand
Journal: J Mol Cell Cardiol Date: 2009-02-21 Impact factor: 5.000

8. Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.

Authors: Robert N Correll; Petra Eder; Adam R Burr; Sanda Despa; Jennifer Davis; Donald M Bers; Jeffery D Molkentin
Journal: Circ Res Date: 2013-11-11 Impact factor: 17.367

9. Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.

Authors: Ruth Isserlin; Daniele Merico; Rasoul Alikhani-Koupaei; Anthony Gramolini; Gary D Bader; Andrew Emili
Journal: Proteomics Date: 2010-03 Impact factor: 3.984

10. Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging.

Authors: Katrin Wittköpper; Larissa Fabritz; Stefan Neef; Katharina R Ort; Clemens Grefe; Bernhard Unsöld; Paulus Kirchhof; Lars S Maier; Gerd Hasenfuss; Dobromir Dobrev; Thomas Eschenhagen; Ali El-Armouche
Journal: J Clin Invest Date: 2010-01-11 Impact factor: 14.808